BioCryst Pharmaceuticals, Inc. Income from Continuous Operations

Income from Continuous Operations of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income from Continuous Operations growth rates and interactive chart.


Highlights and Quick Summary

  • Income from Continuous Operations for the quarter ending September 30, 2022 was $-42.5 Million (a -27.76% decrease compared to previous quarter)
  • Year-over-year quarterly Income from Continuous Operations increased by 139.16%
  • Annual Income from Continuous Operations for 2021 was $-184 Million (a 0.68% increase from previous year)
  • Annual Income from Continuous Operations for 2020 was $-183 Million (a 67.88% increase from previous year)
  • Annual Income from Continuous Operations for 2019 was $-109 Million (a 7.55% increase from previous year)
  • Twelve month Income from Continuous Operations ending September 30, 2022 was $-193 Million (a -7.77% decrease compared to previous quarter)
  • Twelve month trailing Income from Continuous Operations increased by 5.05% year-over-year
Trailing Income from Continuous Operations for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$-193 Million $-210 Million $-194 Million $-184 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income from Continuous Operations of BioCryst Pharmaceuticals, Inc.

Most recent Income from Continuous Operationsof BCRX including historical data for past 10 years.

Interactive Chart of Income from Continuous Operations of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Income from Continuous Operations for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-42.52 $-58.86 $-74.2
2021 $-17.78 $-58.8 $-43.2 $-64.28 $-184.06
2020 $-60.49 $-46.12 $-38.61 $-37.6 $-182.81
2019 $-2.62 $-37.59 $-37.63 $-31.05 $-108.9
2018 $-27.43 $-29.6 $-18.45 $-25.78 $-101.25
2017 $-19.54 $-15.13 $-16.89 $-14.22 $-65.78
2016 $-4.5 $-11.53 $-16.28 $-22.83 $-55.14
2015 $-18.14 $-14.62 $4.9 $-15.16 $-43.02
2014 $-11.67 $-8.73 $-14.65 $-10.14 $-45.19
2013 $-5.43 $-8.0 $-12.17 $-4.51 $-30.11
2012 $-11.05 $-9.7 $-12.28 $-6.05 $-39.08

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology